You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 51 No. 12, December 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Factors Affecting Course and Survival in Alzheimer's Disease

A 9-Year Longitudinal Study

Laura Bracco, MD; Roberta Gallato, PhD; Francesco Grigoletto, PhD; Andrea Lippi, MD; Vito Lepore, MD; Giovanni Bino, MD; Maria Pia Lazzaro, MD; Francesco Carella, MD; Tina Piccolo, MD; Carlo Pozzilli, MD; Bruno Giometto, MD; Luigi Amaducci, MD

Arch Neurol. 1994;51(12):1213-1219.


Abstract

Objective
To evaluate mean survival and to identify prognostic factors in a cohort of patients with Alzheimer's disease (AD).

Design
Multicentric 9-year cohort analytic study.

Setting
Seven neurology departments throughout Italy between April 1982 and January 1984.

Patients
We recruited a consecutive sample of 145 patients affected by probable AD (Multicenter Italian Study on Dementia protocol, National Institute of Neurological Disorders and Stroke-Alzheimer's Disease and Related Disorders Association criteria). Five were misdiagnosed, and 21 could not participate in the longitudinal study. The clinicodemographic characteristics of the 119 enrolled patients (49 men, 70 women; mean age, 64.7 years; SD, 4.1 years; mean duration of disease, 3.1 years; SD, 1.8 years) did not differ from those of the 26 excluded patients. All underwent extensive cliniconeuropsychological testing every 6 months for at least 2 years until the patient died or our survey ended (April 30, 1991). Mean follow-up was 5.1 years (SD, 2.5 years).

Main Outcome Measures
Death, severe functional impairment (a score > 17 on the Blessed Dementia Scale), and severe cognitive impairment (a score of ^7 on the Information-Memory-Concentration Test).

Results
Survival curves obtained by the Kaplan-Meier method indicated that (1) patients with early- and lateonset disease (ie, before or after age 65 years) showed no difference either in relative survival or in time to reach predetermined functional and cognitive end points; (2) severely aphasie patients became profoundly demented significantly sooner than those with mild to moderate aphasia (P<.0001). Among clinicodemographic variables analyzed by a Cox model, severe language disability and functional loss proved to be the best predictors of death independent of age at onset or degree of dementia.

Conclusions
Age at onset did not influence course and survival in AD. Severe aphasia appears to be the best predictor of death and unfavorable course.



Author Affiliations

From the Department of Neurological and Psychiatric Sciences, University of Florence (Drs Bracco, Lippi, and Amaducci); the Department of Biostatistics and Epidemiology, FIDIA, Abano Terme, Padua (Drs Gallato and Grigoletto); the Department of Neurology, University of Bari (Dr Lepore); the Department of Neurology, University of Genoa (Dr Bino); the Department of Neurology, University of L'Aquila (Dr Lazzaro); the Neurological Institute "C. Besta," Milan (Drs Caretta and Piccolo); the Department of Neurological and Psychiatric Sciences, University "La Sapienza," Rome (Dr Pozzi Hi); and the Department of Neurology, University of Padua (Dr Giometto), Italy.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

How fast will it go, doc?: New tools for an old question from patients with Alzheimer disease
Frisoni and Whitwell
Neurology 2008;70:2194-2195.
FULL TEXT  

Race/ethnic differences in AD survival in US Alzheimer's Disease Centers
Mehta et al.
Neurology 2008;70:1163-1170.
ABSTRACT | FULL TEXT  

Evidence-Based Research in Complementary and Alternative Medicine III: Treatment of Patients with Alzheimer's Disease
Chiappelli et al.
Evid Based Complement Alternat Med 2006;3:411-424.
ABSTRACT | FULL TEXT  

Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients
Kim et al.
Brain 2005;128:1790-1801.
ABSTRACT | FULL TEXT  

Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy
Tang-Wai et al.
Neurology 2004;63:1168-1174.
ABSTRACT | FULL TEXT  

Rate of cognitive decline and mortality in Alzheimer's disease
Hui et al.
Neurology 2003;61:1356-1361.
ABSTRACT | FULL TEXT  

Predictors of six-month survival among patients with dementia: An evaluation of hospice Medicare guidelines
Schonwetter et al.
AM J HOSP PALLIAT CARE 2003;20:105-113.
ABSTRACT  

Alzheimer Disease
Cummings and Cole
JAMA 2002;287:2335-2338.
FULL TEXT  

Cognitive and functional decline in African Americans with VaD, AD, and stroke without dementia
Nyenhuis et al.
Neurology 2002;58:56-61.
ABSTRACT | FULL TEXT  

Gender differences in predictors of mortality in nursing home residents with AD
Lapane et al.
Neurology 2001;56:650-654.
ABSTRACT | FULL TEXT  

A Method for Estimating Progression Rates in Alzheimer Disease
Doody et al.
Arch Neurol 2001;58:449-454.
ABSTRACT | FULL TEXT  

Long-term survival, place of death, and death certification in clinically diagnosed pre-senile dementia in northern England: Follow-up after 8-12 years
KAY et al.
Br. J. Psychiatry 2000;177:156-162.
ABSTRACT | FULL TEXT  

Alzheimer's disease due to an intronic presenilin-1 (PSEN1 intron 4) mutation: A clinicopathological study
Janssen et al.
Brain 2000;123:894-907.
ABSTRACT | FULL TEXT  

Predictors of mortality in patients with Alzheimer's disease living in nursing homes
Gambassi et al.
J. Neurol. Neurosurg. Psychiatry 1999;67:59-65.
ABSTRACT | FULL TEXT  

Neurological and Psychiatric Predictors of Mortality in Patients With Alzheimer Disease in California
Moritz et al.
Arch Neurol 1997;54:878-885.
ABSTRACT  

Aphasia May Predict Progression in Alzheimer's
JWatch Psychiatry 1995;1995:6-6.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.